Kilroy Oyster Point — a biotech lab and office development entitled for 2.5 million square feet — will start pile-driving work May 3 as the massive project goes vertical.
Kilroy Realty Corp.'s (NYSE: KRC) 40-acre project, which it bought last year for $308 million, is moving forward in a tight biotech real estate market. It is part of nearly 5 million square feet under construction or recently completed in South San Francisco alone. Hundreds of thousands square feet of additional space is being…
